After-Hours Movers 07/23: (BJRI) (MAT) (AMD) Higher; (EHTH) (INTC) (SWKS) Lower (more...)
After-Hours Movers:
eHealth (NASDAQ: EHTH) 23.7% LOWER; reported Q2 EPS of $0.07, $0.21 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $88.8 million versus the consensus estimate of $80.78 million. eHealth sees FY2020 EPS of $3.83-$4.32, versus the consensus of $3.82. eHealth sees FY2020 revenue of $630-670 million, versus the consensus of $639.48 million.
Clearfield, Inc. (NASDAQ: CLFD) 21.5% HIGHER; Record Revenue Driven by 48% Increase in Multiple System Operator Revenue, 22% Increase in Community Broadband Revenue and 19% Increase in Tier 1 Revenue over Prior Year Quarter, Offset by Lower International Sales.
SciPlay Corporation (NASDAQ: SCPL) 14.6% HIGHER; reported Q2 EPS of $0.27, $0.02 better than the analyst estimate of $0.25. Revenue for the quarter came in at $165.5 million versus the consensus estimate of $137.2 million.
Bj's Restaurants, Inc. (NASDAQ: BJRI) 11.8% HIGHER; reported Q2 EPS of ($1.38), $0.57 better than the analyst estimate of ($1.95). Revenue for the quarter came in at $128 million versus the consensus estimate of $128.64 million.
The Menarini Group and Radius Health, Inc. (Nasdaq: RDUS) 10.2% HIGHER; announced today that the companies have entered into an exclusive global license agreement for development and commercialization of elacestrant.
Intel (NASDAQ: INTC) 10.1% LOWER; reported Q2 EPS of $1.23, $0.12 better than the analyst estimate of $1.11. Revenue for the quarter came in at $19.7 billion versus the consensus estimate of $18.55 billion. Intel sees FY2020 EPS of $4.85, versus the consensus of $4.81. Intel sees FY2020 revenue of $75 billion, versus the consensus of $73.86 billion. Intel sees Q3 EPS of $1.10, versus the consensus of $1.14. Intel sees Q3 revenue of $18.2 billion, versus the consensus of $17.9 billion. Intel's next generations 7nm technology is a month behind schedule.
Mattel (NASDAQ: MAT) 7.7% HIGHER; reported Q2 EPS of ($0.26), $0.08 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $732 million versus the consensus estimate of $678.52 million.
Advanced Micro Devices, Inc. (NASDAQ: AMD) 7.3% HIGHER; Gains tied to news Intel's next generations 7nm technology is a month behind schedule.
Arbutus Biopharma Corporation (NASDAQ: ABUS) 6.5% LOWER; gives back some of today's 120% surge which was related to a patent win against Moderna.
Boston Beer Co. (NYSE: SAM) 6.5% HIGHER; reported Q2 EPS of $4.88, $2.46 better than the analyst estimate of $2.42. Revenue for the quarter came in at $452.1 million versus the consensus estimate of $429.58 million. Boston Beer Co. sees FY2020 EPS of $11.70-$12.70, versus the consensus of $9.54.
NuCana (NASDAQ: NCNA) 5.8% HIGHER; Oppenheimer initiates coverage on with an Outperform rating and a price target of $20.00.
Edwards Lifesciences (NYSE: EW) 5% HIGHER; reported Q2 EPS of $0.34, $0.17 better than the analyst estimate of $0.17. Revenue for the quarter came in at $925 million versus the consensus estimate of $797.53 million. Edwards Lifesciences sees FY2020 EPS of $1.75-$1.95, versus the consensus of $1.63. Edwards Lifesciences sees FY2020 revenue of $4-4.5 billion, versus the consensus of $4.23 billion.
Skyworks Solutions (NASDAQ: SWKS) 2.4% LOWER; reported Q3 EPS of $1.25, $0.13 better than the analyst estimate of $1.12. Revenue for the quarter came in at $736.8 million versus the consensus estimate of $690.67 million. Skyworks Solutions sees Q4 2020 EPS of $1.51, versus the consensus of $1.47. Skyworks Solutions sees Q4 2020 revenue of $830-850 million, versus the consensus of $809.5 million.
Moderna, Inc. (NASDAQ: MRNA) 1.9% LOWER; adds to intra-day losses of 9.5% after losing a patent battle to Arbutus.